Cervical cancer is a very common disease, the third most common cancer in women in the world, especially in developing countries. Statistics on many studies in many regions show that more than 90% of cervical cancer cases are related to HPV.

Vinmec provides Cervarix vaccine that prevents the 4 most common high-risk HPV types that cause cervical cancer. Even with vaccination, cervical cancer screening should still be done periodically in women turning 25.

Cervical cancer screening is a way to find abnormal cell changes in the cervix that can lead to cancer. Screening includes a Pap smear (also called a Pap test) and, for some women, an HPV test.